|
Volumn 359, Issue 9313, 2002, Pages 1249-1251
|
Risk reduction for stroke and coronary events [3] (multiple letters)
e
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CAPTOPRIL;
CHLORTALIDONE;
DIHYDROPYRIDINE;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOXAZOSIN;
ENALAPRIL;
PERINDOPRIL;
RAMIPRIL;
THIAZIDE DIURETIC AGENT;
ANTIHYPERTENSIVE AGENT;
BENZOTHIADIAZINE DERIVATIVE;
ANTIHYPERTENSIVE ACTIVITY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
DEATH;
DIASTOLIC BLOOD PRESSURE;
DRUG EFFECT;
DRUG EFFICACY;
HEART EJECTION FRACTION;
HEART INFARCTION;
HEART LEFT VENTRICLE FAILURE;
HYPERTENSION;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
STROKE;
SYSTOLIC BLOOD PRESSURE;
BLOOD PRESSURE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
HUMAN;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
COMPARATIVE STUDY;
METHODOLOGY;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CEREBROVASCULAR ACCIDENT;
CORONARY DISEASE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BENZOTHIADIAZINES;
CARDIOVASCULAR DISEASES;
DIURETICS;
RAMIPRIL;
SODIUM CHLORIDE SYMPORTER INHIBITORS;
CLINICAL TRIALS;
|
EID: 0037029385
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)08233-8 Document Type: Letter |
Times cited : (2)
|
References (2)
|